Login / Signup

Amantadine as adjuvant therapy in the treatment of moderate to severe obsessive-compulsive disorder: A double-blind randomized trial with placebo control.

Sina NaderiHeidar FaghihAli AqamolaeiSeyyed Hosein MortazaviAmirhosein MortezaeiErfan SahebolzamaniFarzin RezaeiShahin Akhondzadeh
Published in: Psychiatry and clinical neurosciences (2018)
The results of this study suggest that amantadine may be effective as an augmentative agent in the treatment of moderate-to-severe OCD.
Keyphrases
  • obsessive compulsive disorder
  • early onset
  • deep brain stimulation
  • randomized controlled trial
  • combination therapy